市場調査レポート

商品コード

1652029

プロテイナーゼKの世界市場：市場規模・シェア・動向、業界分析 (形状別・治療領域別・エンドユーザー別・地域別)、将来予測 (2025年～2034年)

Proteinase K Market Size, Share, Trends, Industry Analysis Report: By Form (Powder and Liquid), Therapeutic Area, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034

出版日: 2025年01月01日
発行: Polaris Market Research
ページ情報: 英文 117 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 612,127円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 756,157円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 900,187円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.03円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、世界のプロテイナーゼKの市場規模は2034年までに108億7,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

プロテイナーゼK市場の成長は、遺伝子研究、診断、バイオテクノロジーにおける分子生物学ツールの需要増加が牽引しています。主な促進要因としては、個別化医療の人気の高まり、次世代シーケンシング (NGS) およびポリメラーゼ連鎖反応 (PCR) 技術の採用拡大、DNAおよびRNA抽出におけるプロテイナーゼKの使用拡大などが挙げられます。

プロテイナーゼKの市場機会は、医療とバイオテクノロジーの進歩が需要を促進しているアジア太平洋を中心とした新興市場に存在します。安定性を向上させた組換え型を含む酵素生産における技術革新や、精密医療への関心の高まりといった動向が市場を形成しています。全体として、プロテイナーゼK市場の需要は、プロテイナーゼKが分子診断、医薬品開発、遺伝子検査に不可欠になるにつれて拡大し続けると予想されます。

プロテイナーゼK市場：分析概要

保存期間が長く、研究用途に広く使用されていることから、粉末セグメントがプロテイナーゼK市場シェアを独占しています。液剤は、診断や臨床現場での利便性により、急成長を遂げています。

治療分野別では感染症分野が、診断ツールの需要増に牽引されて最大シェアを占めています。がん分野は、個別化がん治療におけるゲノム解析の必要性に後押しされ、最も急成長している分野です。

エンドユーザー別ではバイオテクノロジー企業が、医薬品開発や研究にプロテイナーゼKを幅広く応用していることから、最大の市場シェアを占めています。CRO (医薬品開発業務受託機関) セグメントは、研究活動のアウトソーシングの増加により、最も高い成長率を記録しています。

北米は、高度な医療インフラと分子診断における旺盛な需要に牽引され、プロテイナーゼK市場の収益シェアを独占しています。しかし、中国やインドなどの国々におけるバイオテクノロジーと医療の急速な進歩に支えられ、アジア太平洋が最も高い成長率を示しています。

市場スナップショット
プロテイナーゼKの市場力学
- 促進要因と機会
  - 分子診断における採用の増加
  - 酵素生産技術の進歩
  - 精密医療への注目の高まり
- 抑制要因と課題
  - 生産コストと試薬コストの高さ
PESTLE分析
プロテイナーゼK市場の動向：エンドユーザー別
バリューチェーン分析

第5章世界のプロテイナーゼK市場：形状別

主な調査結果
イントロダクション
粉末
液体

第6章世界のプロテイナーゼK市場：治療領域別

主な調査結果
イントロダクション
感染症
糖尿病
腫瘍
心臓病
その他の治療領域

第7章世界のプロテイナーゼK市場：エンドユーザー別

主な調査結果
イントロダクション
CRO (医薬品開発業務受託機関)
学術機関
バイオテクノロジー企業
診断検査室

第8章世界のプロテイナーゼK市場：地域別

主な調査結果
イントロダクション
- プロテイナーゼK市場の評価：地域別 (2020～2034年)
北米
- 北米：形状別 (2020～2034年)
- 北米：治療領域別 (2020～2034年)
- 北米：エンドユーザー別 (2020～2034年)
- 米国
- カナダ
欧州
- 欧州：形状別 (2020～2034年)
- 欧州：治療領域別 (2020～2034年)
- 欧州：エンドユーザー別 (2020～2034年)
- 英国
- フランス
- ドイツ
- イタリア
- スペイン
- オランダ
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋：形状別 (2020～2034年)
- アジア太平洋：治療領域別 (2020～2034年)
- アジア太平洋：エンドユーザー別 (2020～2034年)
- 中国
- インド
- マレーシア
- 日本
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋
中東・アフリカ
- 中東・アフリカ：形状別 (2020～2034年)
- 中東・アフリカ：治療領域別 (2020～2034年)
- 中東・アフリカ：エンドユーザー別 (2020～2034年)
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- 南アフリカ
- その他中東・アフリカ
ラテンアメリカ
- ラテンアメリカ：形状別 (2020～2034年)
- ラテンアメリカ：治療領域別 (2020～2034年)
- ラテンアメリカ：エンドユーザー別 (2020～2034年)
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ

第9章競合情勢

事業拡大・企業買収の分析
- 事業拡大
- 企業買収
提携/協業/合意/公開

第10章企業プロファイル

Thermo Fisher Scientific
Sigma-Aldrich
New England Biolabs c
Roche
QIAGEN
Promega Corporation
Bio-Rad Laboratories
Abcam
Merck Millipore
VWR International
Takara Bio
Creative Enzymes
Biotech Biochemicals
FUJIFILM Wako Chemicals
Integrated DNA Technologies

図表

List of Tables:

Table 1 Global Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 2 Global Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 3 Global Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 4 North America: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 5 North America: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 6 North America: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 7 U.S.: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 8 U.S.: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 9 U.S.: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 10 Canada: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 11 Canada: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 12 Canada: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 13 Europe: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 14 Europe: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 15 Europe: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 16 UK: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 17 UK: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 18 UK: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 19 France: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 20 France: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 21 France: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 22 Germany: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 23 Germany: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 24 Germany: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 25 Italy: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 26 Italy: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 27 Italy: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 28 Spain: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 29 Spain: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 30 Spain: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 31 Netherlands: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 32 Netherlands: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 33 Netherlands: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 34 Russia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 35 Russia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 36 Russia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 37 Rest of Europe: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 38 Rest of Europe: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 39 Rest of Europe: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 40 Asia Pacific: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 41 Asia Pacific: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 42 Asia Pacific: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 43 China: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 44 China: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 45 China: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 46 India: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 47 India: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 48 India: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 49 Malaysia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 50 Malaysia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 51 Malaysia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 52 Japan: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 53 Japan: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 54 Japan: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 55 Indonesia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 56 Indonesia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 57 Indonesia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 58 South Korea: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 59 South Korea: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 60 South Korea: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 61 Australia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 62 Australia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 63 Australia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 64 Rest of Asia Pacific: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 65 Rest of Asia Pacific: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 66 Rest of Asia Pacific: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 67 Middle East & Africa: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 68 Middle East & Africa: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 69 Middle East & Africa: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 70 Saudi Arabia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 71 Saudi Arabia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 72 Saudi Arabia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 73 UAE: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 74 UAE: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 75 UAE: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 76 Israel: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 77 Israel: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 78 Israel: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 79 South Africa: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 80 South Africa: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 81 South Africa: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 82 Rest of Middle East & Africa: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 83 Rest of Middle East & Africa: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 84 Rest of Middle East & Africa: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 85 Latin America: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 86 Latin America: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 87 Latin America: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 88 Mexico: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 89 Mexico: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 90 Mexico: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 91 Brazil: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 92 Brazil: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 93 Brazil: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 94 Argentina: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 95 Argentina: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 96 Argentina: Proteinase K Market, by End User, 2020-2034 (USD Billion)
Table 97 Rest of Latin America: Proteinase K Market, by Form, 2020-2034 (USD Billion)
Table 98 Rest of Latin America: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
Table 99 Rest of Latin America: Proteinase K Market, by End User, 2020-2034 (USD Billion)

List of Figures:

Figure 1. Global Proteinase K Market, 2020-2034 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Price
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Form
Figure 7. Global Proteinase K Market, by Form, 2024 & 2034 (USD Billion)
Figure 8. Market by Therapeutic Area
Figure 9. Global Proteinase K Market, by Therapeutic Area, 2024 & 2034 (USD Billion)
Figure 10. Market by End User
Figure 11. Global Proteinase K Market, by End User, 2024 & 2034 (USD Billion)

Product Code: PM1768

The global Proteinase K market size is expected to reach USD 10.87 billion by 2034, according to a new study by Polaris Market Research. The report "Proteinase K Market Size, Share, Trends, Industry Analysis Report: By Form (Powder and Liquid), Therapeutic Area, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Proteinase K market growth is driven by the increasing demand for molecular biology tools in genetic research, diagnostics, and biotechnology. Key drivers include the rising popularity of personalized medicine, growing adoption of next-generation sequencing (NGS) and polymerase chain reaction (PCR) technologies, and the expanding use of Proteinase K in DNA and RNA extraction.

Proteinase K market opportunities exist in emerging markets, particularly in Asia Pacific, where advancements in healthcare and biotechnology are fostering demand. Trends such as innovations in enzyme production, including recombinant variants with improved stability, and the growing focus on precision medicine are shaping the market. Overall, the Proteinase K market demand is expected to continue expanding as Proteinase K becomes more essential in molecular diagnostics, drug development, and genetic testing.

Proteinase K Market Report Highlights:

Based on form. the powder segment dominates the Proteinase K market share due to its longer shelf life and widespread use in research applications. The liquid segment is witnessing the fastest growth, driven by its convenience in diagnostic and clinical settings.

By therapeutic area, the infectious diseases segment holds the largest share, driven by the increasing demand for diagnostic tools. The oncology segment is the fastest-growing segment, fueled by the need for genomic analysis in personalized cancer therapies.

The biotechnology companies segment, by end user, holds the largest market share due to their broad application of Proteinase K in drug development and research. The contract research organizations (CROs) segment is registering the highest growth rate due to the increasing outsourcing of research activities.

North America dominates the Proteinase K market revenue share, driven by advanced healthcare infrastructure and strong demand in molecular diagnostics. However, Asia Pacific is the highest-growing region, supported by rapid advancements in biotechnology and healthcare in countries such as China and India.

Polaris Market Research has segmented the Proteinase K market report on the basis of form, therapeutic area, end user, and region:

By Form Outlook (Revenue - USD Billion, 2020-2034)

Powder
Liquid

By Therapeutic Area Outlook (Revenue - USD Billion, 2020-2034)

Infectious Diseases
Diabetes
Oncology
Cardiology
Other Therapeutic Areas

By End User Outlook (Revenue - USD Billion, 2020-2034)

Contract Research Organization
Academic Institutes
Biotechnology Companies
Diagnostic Laboratories

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Proteinase K Market Insights

4.1. Proteinase K Market - Market Snapshot
4.2. Proteinase K Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increasing Adoption in Molecular Diagnostics
  - 4.2.1.2. Advancements in Enzyme Production Technology
  - 4.2.1.3. Rising Focus on Precision Medicine
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of Production and Reagents
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Proteinase K Market End User Trends
4.6. Value Chain Analysis

5. Global Proteinase K Market, by Form

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Proteinase K Market, by Form, 2020-2034 (USD Billion)
5.3. Powder
- 5.3.1. Global Proteinase K Market, by Powder, by Region, 2020-2034 (USD Billion)
5.4. Liquid
- 5.4.1. Global Proteinase K Market, by Liquid, by Region, 2020-2034 (USD Billion)

6. Global Proteinase K Market, by Therapeutic Area

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
6.3. Infectious Diseases
- 6.3.1. Global Proteinase K Market, by Infectious Diseases, by Region, 2020-2034 (USD Billion)
6.4. Diabetes
- 6.4.1. Global Proteinase K Market, by Diabetes, by Region, 2020-2034 (USD Billion)
6.5. Oncology
- 6.5.1. Global Proteinase K Market, by Oncology, by Region, 2020-2034 (USD Billion)
6.6. Cardiology
- 6.6.1. Global Proteinase K Market, by Cardiology, by Region, 2020-2034 (USD Billion)
6.7. Other Therapeutic Areas
- 6.7.1. Global Proteinase K Market, by Other Therapeutic Areas, by Region, 2020-2034 (USD Billion)

7. Global Proteinase K Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Proteinase K Market, by End User, 2020-2034 (USD Billion)
7.3. Contract Research Organization
- 7.3.1. Global Proteinase K Market, by Contract Research Organization, by Region, 2020-2034 (USD Billion)
7.4. Academic Institutes
- 7.4.1. Global Proteinase K Market, by Academic Institutes, by Region, 2020-2034 (USD Billion)
7.5. Biotechnology Companies
- 7.5.1. Global Proteinase K Market, by Biotechnology Companies, by Region, 2020-2034 (USD Billion)
7.6. Diagnostic Laboratories
- 7.6.1. Global Proteinase K Market, by Diagnostic Laboratories, by Region, 2020-2034 (USD Billion)

8. Global Proteinase K Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Proteinase K Market Assessment, By Geography, 2020-2034 (USD Billion)
8.3. Proteinase K Market - North America
- 8.3.1. North America: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.3.2. North America: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.3.3. North America: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.3.4. Proteinase K Market - U.S.
  - 8.3.4.1. U.S.: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.3.4.2. U.S.: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.3.4.3. U.S.: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.3.5. Proteinase K Market - Canada
  - 8.3.5.1. Canada: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.3.5.2. Canada: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.3.5.3. Canada: Proteinase K Market, by End User, 2020-2034 (USD Billion)
8.4. Proteinase K Market - Europe
- 8.4.1. Europe: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.4.2. Europe: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.4.3. Europe: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.4. Proteinase K Market - UK
  - 8.4.4.1. UK: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.4.4.2. UK: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.4.4.3. UK: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.5. Proteinase K Market - France
  - 8.4.5.1. France: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.4.5.2. France: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.4.5.3. France: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.6. Proteinase K Market - Germany
  - 8.4.6.1. Germany: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.4.6.2. Germany: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.4.6.3. Germany: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.7. Proteinase K Market - Italy
  - 8.4.7.1. Italy: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.4.7.2. Italy: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.4.7.3. Italy: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.8. Proteinase K Market - Spain
  - 8.4.8.1. Spain: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.4.8.2. Spain: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.4.8.3. Spain: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.9. Proteinase K Market - Netherlands
  - 8.4.9.1. Netherlands: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.10. Proteinase K Market - Russia
  - 8.4.10.1. Russia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.4.10.2. Russia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.4.10.3. Russia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.4.11. Proteinase K Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Proteinase K Market, by End User, 2020-2034 (USD Billion)
8.5. Proteinase K Market - Asia Pacific
- 8.5.1. Asia Pacific: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.5.2. Asia Pacific: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.5.3. Asia Pacific: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.4. Proteinase K Market - China
  - 8.5.4.1. China: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.5.4.2. China: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.5.4.3. China: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.5. Proteinase K Market - India
  - 8.5.5.1. India: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.5.5.2. India: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.5.5.3. India: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.6. Proteinase K Market - Malaysia
  - 8.5.6.1. Malaysia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.7. Proteinase K Market - Japan
  - 8.5.7.1. Japan: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.5.7.2. Japan: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.5.7.3. Japan: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.8. Proteinase K Market - Indonesia
  - 8.5.8.1. Indonesia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.9. Proteinase K Market - South Korea
  - 8.5.9.1. South Korea: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.5.9.2. South Korea: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.5.9.3. South Korea: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.10. Proteinase K Market - Australia
  - 8.5.10.1. Australia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.5.10.2. Australia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.5.10.3. Australia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.5.11. Proteinase K Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Proteinase K Market, by End User, 2020-2034 (USD Billion)
8.6. Proteinase K Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.6.4. Proteinase K Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.6.5. Proteinase K Market - UAE
  - 8.6.5.1. UAE: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.6.5.2. UAE: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.6.5.3. UAE: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.6.6. Proteinase K Market - Israel
  - 8.6.6.1. Israel: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.6.6.2. Israel: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.6.6.3. Israel: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.6.7. Proteinase K Market - South Africa
  - 8.6.7.1. South Africa: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.6.7.2. South Africa: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.6.7.3. South Africa: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.6.8. Proteinase K Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Proteinase K Market, by End User, 2020-2034 (USD Billion)
8.7. Proteinase K Market - Latin America
- 8.7.1. Latin America: Proteinase K Market, by Form, 2020-2034 (USD Billion)
- 8.7.2. Latin America: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
- 8.7.3. Latin America: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.7.4. Proteinase K Market - Mexico
  - 8.7.4.1. Mexico: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.7.4.2. Mexico: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.7.4.3. Mexico: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.7.5. Proteinase K Market - Brazil
  - 8.7.5.1. Brazil: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.7.5.2. Brazil: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.7.5.3. Brazil: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.7.6. Proteinase K Market - Argentina
  - 8.7.6.1. Argentina: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.7.6.2. Argentina: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.7.6.3. Argentina: Proteinase K Market, by End User, 2020-2034 (USD Billion)
- 8.7.7. Proteinase K Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Proteinase K Market, by Form, 2020-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Proteinase K Market, by Therapeutic Area, 2020-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Proteinase K Market, by End User, 2020-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. Thermo Fisher Scientific
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Sigma-Aldrich
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. New England Biolabs c
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Roche
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. QIAGEN
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Promega Corporation
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Bio-Rad Laboratories
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Abcam
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Merck Millipore
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. VWR International
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Takara Bio
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
10.12. Creative Enzymes
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
10.13. Biotech Biochemicals
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
10.14. FUJIFILM Wako Chemicals
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
10.15. Integrated DNA Technologies
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development

プロテイナーゼKの世界市場：市場規模・シェア・動向、業界分析 (形状別・治療領域別・エンドユーザー別・地域別)、将来予測 (2025年～2034年)

Proteinase K Market Size, Share, Trends, Industry Analysis Report: By Form (Powder and Liquid), Therapeutic Area, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034

プロテイナーゼK市場：分析概要

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章プロテイナーゼK市場の洞察

第5章世界のプロテイナーゼK市場：形状別

第6章世界のプロテイナーゼK市場：治療領域別

第7章世界のプロテイナーゼK市場：エンドユーザー別

第8章世界のプロテイナーゼK市場：地域別

第9章競合情勢

第10章企業プロファイル

List of Tables:

List of Figures:

Proteinase K Market Report Highlights:

By Form Outlook (Revenue - USD Billion, 2020-2034)

By Therapeutic Area Outlook (Revenue - USD Billion, 2020-2034)

By End User Outlook (Revenue - USD Billion, 2020-2034)

By Regional Outlook (Revenue - USD Billion, 2020-2034)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Proteinase K Market Insights

5. Global Proteinase K Market, by Form

6. Global Proteinase K Market, by Therapeutic Area

7. Global Proteinase K Market, by End User

8. Global Proteinase K Market, by Geography

9. Competitive Landscape

10. Company Profiles

プロテイナーゼKの世界市場：市場規模・シェア・動向、業界分析 (形状別・治療領域別・エンドユーザー別・地域別)、将来予測 (2025年～2034年)

Proteinase K Market Size, Share, Trends, Industry Analysis Report: By Form (Powder and Liquid), Therapeutic Area, End User, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034

プロテイナーゼK市場：分析概要

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 プロテイナーゼK市場の洞察

第5章 世界のプロテイナーゼK市場：形状別

第6章 世界のプロテイナーゼK市場：治療領域別

第7章 世界のプロテイナーゼK市場：エンドユーザー別

第8章 世界のプロテイナーゼK市場：地域別

第9章 競合情勢

第10章 企業プロファイル

List of Tables:

List of Figures:

Proteinase K Market Report Highlights:

By Form Outlook (Revenue - USD Billion, 2020-2034)

By Therapeutic Area Outlook (Revenue - USD Billion, 2020-2034)

By End User Outlook (Revenue - USD Billion, 2020-2034)

By Regional Outlook (Revenue - USD Billion, 2020-2034)

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Proteinase K Market Insights

5. Global Proteinase K Market, by Form

6. Global Proteinase K Market, by Therapeutic Area

7. Global Proteinase K Market, by End User

8. Global Proteinase K Market, by Geography

9. Competitive Landscape

10. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章プロテイナーゼK市場の洞察

第5章世界のプロテイナーゼK市場：形状別

第6章世界のプロテイナーゼK市場：治療領域別

第7章世界のプロテイナーゼK市場：エンドユーザー別

第8章世界のプロテイナーゼK市場：地域別

第9章競合情勢

第10章企業プロファイル